HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $73 Price Target

Benzinga · 10/16 10:58
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $73 price target.